Tubular injury: The first symptom of hypertensive kidney involvement?

Medical Science Monitor

Volumn 9, Issue 4, 2003, Pages

  Tylicki, Leszek ^a   Manitius, Jacek ^a   Łysiak Szydłowska, Wiesława ^a   Rutkowski, Bolesław ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Hypertensive nephropathy; Metabolic disturbances; N acetyl glucosaminidase; Nephroangiosclerosis; Primary hypertension; Tubules

Indexed keywords

ALBUMIN; GLUCOSE; INSULIN; LIPID; N ACETYL BETA GLUCOSAMINIDASE; URIC ACID;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLOMERULOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY TUBULE DAMAGE; LIPID BLOOD LEVEL; MALE; METABOLIC DISORDER; OPHTHALMOSCOPY; PURINE METABOLISM; RENOVASCULAR HYPERTENSION; SYMPTOMATOLOGY; URIC ACID BLOOD LEVEL;

ACETYLGLUCOSAMINIDASE; ADOLESCENT; ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; FEMALE; FRUCTOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; INSULIN; KIDNEY DISEASES; KIDNEY TUBULES; LIPIDS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; URIC ACID;

EID: 0037545619     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Rutkowski B, Tylicki L, Manitius J, Lysiak-Szydlowska W: Hypertensive nephropathy - an increasing clinical problem. Miner Electolyte Metab, 1999; 25: 65-68
2. Heptinstall RH: Essential hypertension: in: Pathology of the Kidney, Boston, Little, Brown and Company, 1983; 181-245
3. D'Amico G: Tubulo-interstitial damage in glomerular diseases: its role in the progression of the renal damage. Nephrol Dial Transplant, 1998; 13(Suppl 1): 80-85
4. Mai M, Geiger H, Hilgers KF et al: Early interstitial changes in hypertension-induced renal injury. Hypertension, 1993; 22: 754-765
5. Johnson RJ, Alpers CE, Yoshinuura A et al: Renal injury from angiotensin 11-mediated hypertension. Hypertension, 1992; 19: 464-474
6. Tylicki L, Rutkowski B, Hörl HW: Multifactorial determination of hypertensive nephrosclerosis. Kidney Blood Press Res, 2002; 25: 341-35
7. Fournier A, El Esper N, Makdassi R et al: Hypertension and progression of renal insufficiency. Nephrol Dial Transplant, 1994; 3: 28-34
8. Wellwood J M, Ellis BG, Price RG et al: Urinary N-acetyl-β-D-glucosaminidase activities in patients with renal disease. Br Med J, 1975; 3: 411-413
9. Price RG: Urinary enzymes, nephrotoxicity and renal disease. Toxicol, 1982; 23: 99-134
10. Fede C, Conti G, Chimenz R, Ricca M: N-acetyl-D-glucosaminidase and beta-2 microglobulin: prognostic markers in idiopathic nephritic syndrome. J Nephrol, 1999; 12: 51-55
11. Sherman RL, Drayer DE, Leyland-Jones BR, Reidenberg MM: Nacetyl-D-glucosaminidase and beta-2-microglobulin; their urinary excretion in patients with renal parenchymal disease. Arch Intern Med, 1983; 143: 1183-1185
12. Agardh CD, Agardh E, Isaksson A, hultberg B: Association between urinary N-acetyl-D-glucosaminidase and its izoenzyme patterns and microangiopathy in type 1 diabetes mellitus. Clin Chem, 1991; 37: 1696-1699
13. Edwards LC, Heldermann JH, Hamm LL et al: Non-invasive monitoring of renal transplant function by analysis of beta-2-microglobulin. Kidney Int, 1983; 23: 767-770
14. Mueller PW, Hall WD, Caudill SP et al: An in-deph examination of the excretion of albumin and other sensitive markers of renal damage in mild hypertension. Am J Hypertens, 1995; 8: 1072-1082
15. Marczewski K, Krawczyk W, Grzywna R et al: Microproteinuria and circadian rhythm of blood pressure in patients with arterial hypertension. Pol Arch Med Wewn, 1996; 95: 29-34
16. Rustom R, Costigan M, Shenkin A, Bone JM: Proteinuria and renal tubular damage: urinary N-acetyl-D-glucosaminidase and isoenzymes in dissimilar renal disease. Am J Nephrol, 1998; 18: 179-185
17. 1999 World Health Organisation-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. Journal of Hypertension, 1999; 17: 151-183
18. Johnston IDA, Jones NF, Scoble JE et al: The diagnostic value of urinary enzyme measurements in hypertension. Clin Chim Acta, 1983; 133: 317-325
19. Manitius J, Biedunkiewicz B, Kustosz J, Rutkowski B: The relationship between insulin, glucose and serum uric acid and their contribution to the progression of renal damage in patients with primary glomerulonephritis. J Int Medical Research, 1996; 24: 449-453
20. Maruhn D: Rapid calorimetric assay of b-galactosidase and N-acetylβ-glucosaminidase in human urine. Clin Chim Acta, 1976; 73: 453-61
21. Nath KA: The tubulointerstitium in progressive renal disease. Kidney Int, 1998; 54: 992-994
22. Luft FC, Haller H: Hypertension-induced renal injury: is mechanically mediate interstitial inflammation involved? Nephrol Dial Transplant, 1995; 10: 9-11
23. Alderman MH, Melcher L, Drayer DE, Reidenberg MM: Increased excretion of urinary N-acetyl-β-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. N Engl J Med, 1983; 309: 1213-1217
24. Simon G, Morioka S, Snyder DK: Increased serum and urinary Nacetyl-β-D-glucosaminidase activity in human hypertension: early indicator of renal dysfunction. Clin Exper Hypertens, 1984; A6: 879-896
25. Kretowicz M, Ukleja-Adamowicz M, Strozecki P et al: Does any relationship exist between metabolic disturbances and some markers of renal damage in patients with untreated essential hypertension? Pol Arch Med Wewn, 2000; 104: 563-7
26. Bosomworth M, Aparicio SR, Hay AWM: Urinary N-acetyl-β-D-glucosaminidase: a marker of tubular damage? Nephrol Dial Transplant, 1999; 14: 620-625
27. Healy E, Brady HR: Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. Curr Opin Nephrol Hypertens, 1998; 7: 525-530
28. Meyrier A, Hill GS, Simon P: Ischemic renal disease: new insights into old entities. Kidney Int, 1998; 54: 2-13
29. Tracy RE, Strong JP, Newman III WP et al: Renovasculopathies of nephrosclerosis in relation to atherosclerosis at age 25 to 54 years. Kidney Int, 1990; 49: 564-570
30. Zavaroni I, Bonini L, Fantuzzi M et al: Hyperinsulinemia, obesity and syndrome X. J Intern Med, 1994; 235: 51-56
31. Nickeleit V, Mihatsch MJ: Uric acid nephropathy and end-stage renal disease-review of a non-disease. Nephrol Dial Transplant, 1997; 12: 1832-1838
32. Kasiske BL, O'Donnell MP, Cowardin W, Keane WF: Lipids and kidney. Hypertension, 1990; 15: 443-450
33. Hsiao PH, Tsai WS, Tsai WY et al: Urinary N-acetyl-β-D-glucosaminidase activity in children with insulin-dependent diabetes mellitus. Am J Nephrol, 1996; 16: 300-303
34. Stirpe F, Della Corte E, Bonetti E et al: Fructose induced hyperuricemia. Lancet, 1970; 2: 1310-1313
35. Cannon PJ, Stason WB, Demartini FE et al: Hyperuricemia in primary and renal hypertension. N Eng J Med, 1966; 275: 457-464
36. Ruilope LM, Campo C, Rodriguez-Artalejo F et al: Blood pressure and renal function: therapeutic implications. J Hypertens, 1996; 14: 1259-1263
37. Ruilope LM, Alcazar JM, Hernandez E et al: Metabolic alterations accompanying essential hypertension are associated with nephrosclerosis. J Hypertens, 1993; 11(Suppl 5): 475(abstract)
38. Ruilope LM, Alcazar JM, Hernandez E et al: Does an adequate control of blood pressure protect the kidney in essential hypertension? J Hypertens, 1990; 8: 525-531
39. Doria A, Fioretto P, Avogaro A et al: Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol, 1991; 261: 684-691
40. Dengel DR, Goldberg AP, Mayuga RS et al: Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension, 1996; 28: 127-32